These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 20950778

  • 1. Efficacy and safety of the doxazosin gastrointestinal therapeutic system for the treatment of benign prostate hyperplasia.
    Sun GH, Tsui KH, Wu TT, Chang CH, Cheng CL, Schou M.
    Kaohsiung J Med Sci; 2010 Oct; 26(10):532-9. PubMed ID: 20950778
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
    Chung BH, Hong SJ.
    BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335
    [Abstract] [Full Text] [Related]

  • 4. Controlled-release doxazosin in the treatment of benign prostatic hyperplasia.
    Hernandez C, Duran R, Jara J, Castaño I, Moralejo M.
    Prostate Cancer Prostatic Dis; 2005 Jan; 8(4):375-80. PubMed ID: 16264771
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.
    Chung BH, Hong SJ, Lee MS.
    Int J Urol; 2005 Feb; 12(2):159-65. PubMed ID: 15733110
    [Abstract] [Full Text] [Related]

  • 10. Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.
    Chung MS, Lee SH, Park KK, Yoo SJ, Chung BH.
    Int J Clin Pract; 2011 Nov; 65(11):1193-9. PubMed ID: 21995695
    [Abstract] [Full Text] [Related]

  • 11. A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia.
    Roehrborn CG, Prajsner A, Kirby R, Andersen M, Quinn S, Mallen S.
    Eur Urol; 2005 Sep; 48(3):445-52; discussion 452. PubMed ID: 15996811
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.
    Fitzpatrick JM, Desgrandchamps F.
    BJU Int; 2005 Mar; 95(4):575-9. PubMed ID: 15705083
    [Abstract] [Full Text] [Related]

  • 14. Doxazosin gastrointestinal therapeutic system versus tamsulosin for the treatment of benign prostatic hyperplasia: a study in Chinese patients.
    Xue Z, Zhang Y, Ding Q, He Z, Wang J, Xu K.
    Int J Urol; 2007 Feb; 14(2):118-22. PubMed ID: 17302567
    [Abstract] [Full Text] [Related]

  • 15. Terazosin and doxazosin in the treatment of BPH: results of a randomized study with crossover in non-responders.
    Samli MM, Dincel C.
    Urol Int; 2004 Feb; 73(2):125-9. PubMed ID: 15331896
    [Abstract] [Full Text] [Related]

  • 16. A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil.
    Pompeo AC, Rosenblatt C, Bertero E, DA Ros CT, Cairoli CE, Damião R, Wroclawski ER, Koff WJ, Mesquita F, Pinheiro GE, Doxazosin and Tamsulosin Study Investigator Group.
    Int J Clin Pract; 2006 Oct; 60(10):1172-7. PubMed ID: 16942589
    [Abstract] [Full Text] [Related]

  • 17. [Clinical effectiveness and safety of combined therapy with an alpha-blocker and an anticholinergic drug for patients with benign prostatic hyperplasia].
    Xiao H, Li HZ, Huang ZM, Li YQ.
    Zhonghua Wai Ke Za Zhi; 2010 Dec 01; 48(23):1771-3. PubMed ID: 21211380
    [Abstract] [Full Text] [Related]

  • 18. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
    Tsai YS, Lan SK, Ou JH, Tzai TS.
    Clin Ther; 2007 Apr 01; 29(4):670-82. PubMed ID: 17617290
    [Abstract] [Full Text] [Related]

  • 19. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.
    de Reijke TM, Klarskov P.
    BJU Int; 2004 Apr 01; 93(6):757-62. PubMed ID: 15049986
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.